Henry Schein (NASDAQ:HSIC) PT Raised to $71.00

Henry Schein (NASDAQ:HSIC) had its target price raised by research analysts at Bank of America from $69.00 to $71.00 in a research note issued on Tuesday, BenzingaRatingsTable reports. The brokerage currently has a “neutral” rating on the stock. Bank of America‘s target price indicates a potential upside of 3.66% from the company’s previous close.

Other equities analysts also recently issued reports about the company. Barrington Research restated a “buy” rating and issued a $75.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. ValuEngine upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Tuesday. BidaskClub raised Henry Schein from a “hold” rating to a “buy” rating in a report on Wednesday, November 27th. Piper Jaffray Companies boosted their price objective on Henry Schein from $72.00 to $80.00 and gave the company an “overweight” rating in a research report on Monday, November 11th. Finally, TheStreet upgraded Henry Schein from a “c+” rating to a “b” rating in a research report on Monday, October 14th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $72.08.

Henry Schein stock opened at $68.50 on Tuesday. Henry Schein has a 1 year low of $56.58 and a 1 year high of $72.81. The firm’s 50-day moving average is $66.15 and its 200-day moving average is $65.81. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.92 and a current ratio of 1.63. The company has a market cap of $10.11 billion, a P/E ratio of 16.58, a PEG ratio of 2.71 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.90 earnings per share for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.52 billion. Henry Schein had a net margin of 4.66% and a return on equity of 15.93%. The company’s revenue for the quarter was up 6.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.03 EPS. As a group, sell-side analysts predict that Henry Schein will post 3.45 earnings per share for the current year.

Henry Schein announced that its Board of Directors has approved a stock repurchase plan on Thursday, October 31st that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 4.3% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

In related news, Vice Chairman James P. Breslawski sold 6,856 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $66.96, for a total value of $459,077.76. Following the completion of the transaction, the insider now directly owns 242,190 shares of the company’s stock, valued at approximately $16,217,042.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Michael S. Ettinger sold 3,671 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $66.96, for a total value of $245,810.16. Following the completion of the sale, the senior vice president now owns 87,972 shares in the company, valued at $5,890,605.12. The disclosure for this sale can be found here. Insiders sold 123,655 shares of company stock worth $8,373,585 in the last 90 days. 1.06% of the stock is owned by company insiders.

A number of hedge funds have recently made changes to their positions in the business. AGF Investments Inc. raised its holdings in Henry Schein by 6.2% in the 2nd quarter. AGF Investments Inc. now owns 2,816 shares of the company’s stock valued at $197,000 after acquiring an additional 164 shares in the last quarter. Squar Milner Financial Services LLC lifted its position in Henry Schein by 9.3% during the second quarter. Squar Milner Financial Services LLC now owns 2,037 shares of the company’s stock worth $142,000 after purchasing an additional 173 shares during the period. World Asset Management Inc grew its stake in Henry Schein by 1.7% during the third quarter. World Asset Management Inc now owns 10,850 shares of the company’s stock worth $689,000 after buying an additional 178 shares in the last quarter. Rational Advisors LLC grew its stake in Henry Schein by 24.9% during the second quarter. Rational Advisors LLC now owns 903 shares of the company’s stock worth $63,000 after buying an additional 180 shares in the last quarter. Finally, Advisor Group Inc. grew its stake in Henry Schein by 3.8% during the second quarter. Advisor Group Inc. now owns 5,569 shares of the company’s stock worth $388,000 after buying an additional 204 shares in the last quarter.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also: What sectors are represented in the FTSE 100 index?

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.